Patent · US Active

Anti-VEGF protein compositions and methods for producing the same

US11753459B2 · kind B2 · utility

3Cited by

70References

30Claims

0Family size

Assignee

REGENERON PHARMACEUTICALS, INC. · US

Inventors

Shunhai Wang · Scarsdale, US
Ning Li · New Canaan, US
Hunter Chen · New York, US
Amardeep Singh Bhupender Bhalla · Montvale, US
Shawn Lawrence · Nyack, US
Amy S. Johnson · Briarcliff Manor, US
Meghan Casey · Ringwood, US
Jaimie Grapel · Waldwick, US

Key dates

Filing date	Jul 6, 2022
Grant date	Sep 12, 2023
Priority date	—
Expiry date	Jul 6, 2042

Classification

Technology area (CPC G)Physics
CPC primaryG01N2030/027
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure pertains to compositions comprising anti-VEGF proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.